Literature DB >> 19275758

Targeting Myc in pediatric malignancies of the central and peripheral nervous system.

Michael A Grotzer1, Deborah Castelletti, Giulio Fiaschetti, Tarek Shalaby, Alexandre Arcaro.   

Abstract

Myc family genes are often deregulated in embryonal tumors of childhood including medulloblastoma and neuroblastoma and are frequently associated with aggressive, poorly differentiated tumors. The Myc protein is a transcription factor that regulates a variety of cellular processes including cell growth and proliferation, cell cycle progression, differentiation, apoptosis, and cell motility. Potential strategies that either inhibit the proliferation-promoting effect of Myc and/or activate its pro-apoptotic function are presently being explored. In this review, we will give an overview of Myc activation in embryonal tumors and discuss current strategies aimed at targeting Myc for cancer treatment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19275758     DOI: 10.2174/156800909787580962

Source DB:  PubMed          Journal:  Curr Cancer Drug Targets        ISSN: 1568-0096            Impact factor:   3.428


  6 in total

1.  CDK/CK1 inhibitors roscovitine and CR8 downregulate amplified MYCN in neuroblastoma cells.

Authors:  C Delehouzé; K Godl; N Loaëc; C Bruyère; N Desban; N Oumata; H Galons; T I Roumeliotis; E G Giannopoulou; J Grenet; D Twitchell; J Lahti; N Mouchet; M-D Galibert; S D Garbis; L Meijer
Journal:  Oncogene       Date:  2013-12-09       Impact factor: 9.867

2.  CDK Inhibitors Roscovitine and CR8 Trigger Mcl-1 Down-Regulation and Apoptotic Cell Death in Neuroblastoma Cells.

Authors:  Karima Bettayeb; Dianne Baunbæk; Claire Delehouze; Nadège Loaëc; Alison J Hole; Sonja Baumli; Jane A Endicott; Setha Douc-Rasy; Jean Bénard; Nassima Oumata; Hervé Galons; Laurent Meijer
Journal:  Genes Cancer       Date:  2010-04

3.  Characterization of critical domains within the tumor suppressor CASZ1 required for transcriptional regulation and growth suppression.

Authors:  Ryan A Virden; Carol J Thiele; Zhihui Liu
Journal:  Mol Cell Biol       Date:  2012-02-13       Impact factor: 4.272

4.  Novel agents targeting the IGF-1R/PI3K pathway impair cell proliferation and survival in subsets of medulloblastoma and neuroblastoma.

Authors:  Anna Wojtalla; Fabiana Salm; Ditte G Christiansen; Tiziana Cremona; Paulina Cwiek; Tarek Shalaby; Nicole Gross; Michael A Grotzer; Alexandre Arcaro
Journal:  PLoS One       Date:  2012-10-08       Impact factor: 3.240

Review 5.  Prognostic Value of Molecular Markers and Implication for Molecular Targeted Therapies in Nasopharyngeal Carcinoma: An Update in an Era of New Targeted Molecules Development.

Authors:  Mu-Tai Liu; Mu-Kuan Chen; Chia-Chun Huang; Chao-Yuan Huang
Journal:  World J Oncol       Date:  2015-02-14

6.  The Phosphoinositide 3-Kinase p110α Isoform Regulates Leukemia Inhibitory Factor Receptor Expression via c-Myc and miR-125b to Promote Cell Proliferation in Medulloblastoma.

Authors:  Fabiana Salm; Valeriya Dimitrova; André O von Bueren; Paulina Ćwiek; Hubert Rehrauer; Valentin Djonov; Pascale Anderle; Alexandre Arcaro
Journal:  PLoS One       Date:  2015-04-27       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.